TailorMed
OneCell Diagnostics scores $16 million for genomics-based precision oncology and dannce.ai, a phenotyping platform to digitize clinical assessments, secures $2.6 million.
The companies position the acquisition as a way to reduce costs for patients and improve the financial health of provider organizations.
Also: TailorMed extends its funding round to $25 million, and Heydoc closes an $8.3 million Series A.